The inventive subject matter provides compositions and methods for reducing serum levels of at least one biomarker associated with a lipid or liver-related condition. Preferred compositions include a set of actives that consists essentially of at least two saccharides selected from galacturonic acid, galactose, arabinose, rhamnose, glucose, xylose, and mannose.